Monitoring spatial product temperature variation is critical to process development and scale-up in the pharma/bio-pharmaceutical industry. While using...
EMD Millipore | Recorded the 13-Apr-2016 | Webinar
As many biologics will or have come off patent, the opportunity for competition, and potentially lower costs through biosimilars, is created. Barriers...
IMA: 50 years of innovation in processing and packaging machines | Recorded the 22-Apr-2016 | Webinar
The freeze drying community has dedicated resources for artificially inducing nucleation since it was introduced to the community as a means for reliable...
Merck KGaA, Darmstadt, Germany | Recorded the 09-Apr-2015 | Webinar
Pyrogens in pharmaceuticals, medical devices, biotherapeutics and cosmetics can cause fevers in humans and are potentially life-threatening. Yet standard...
Fujifilm Diosynth Biotechnologies | Recorded the 28-May-2014 | Webinar
The development of large scale E. coli expression systems can be rate limiting in process development. Fujifilm's pAVEway™ system combines innovative...
Fujifilm Diosynth Biotechnologies | Recorded the 10-Dec-2013 | Webinar
ADCs are showing great promise as a new therapeutic entity, but have a complex supply chain requiring biologics and high potency capability. This presentation...
ATMI Life Science | Recorded the 19-Sep-2013 | Webinar
Single-use bioprocessing technologies raise persistent concerns about integrity. Sterility of the bag must be maintained in order to avoid contamination...
ATMI Life Science | Recorded the 16-May-2013 | Webinar
The Integrity® LevMixer® single-use mixing system from ATMI LifeSciences is an innovative, low shear and low particulate mixing platform designed for manufacturing...
Piramal Healthcare Ltd | Recorded the 24-May-2013 | Webinar
With the recent approvals of brentuximab vedotin (Adcetris) and ado-trastuzumab emtansine (Kadcyla,T-DM1), antibody–drug conjugates (ADCs)are a rapidly...
Baxter BioPharma Solutions | Recorded the 12-Sep-2012 | Webinar
This webinar will discuss development of design spaces for lyophilized pharmaceutical products in the context of the Quality by Design regulatory paradigm. ...
